3-112102960-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_024616.3(C3orf52):c.391G>A(p.Glu131Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,612,038 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_024616.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C3orf52 | NM_024616.3 | c.391G>A | p.Glu131Lys | missense_variant | 3/6 | ENST00000264848.10 | NP_078892.3 | |
C3orf52 | NM_001171747.2 | c.391G>A | p.Glu131Lys | missense_variant | 3/4 | NP_001165218.1 | ||
C3orf52 | XR_007095726.1 | n.410G>A | non_coding_transcript_exon_variant | 3/8 | ||||
C3orf52 | XR_924171.4 | n.410G>A | non_coding_transcript_exon_variant | 3/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C3orf52 | ENST00000264848.10 | c.391G>A | p.Glu131Lys | missense_variant | 3/6 | 1 | NM_024616.3 | ENSP00000264848.5 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000447 AC: 11AN: 246320Hom.: 0 AF XY: 0.0000225 AC XY: 3AN XY: 133446
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1459864Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 725956
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152174Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74326
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 19, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at